CURI trades 99.2% below Wall Street's consensus target of $5.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CURI achieves its forward estimates and maintains a stable P/E multiple of 12.7x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, CuriosityStream Inc. (CURI) has a Wall Street consensus price target of $5.00, based on estimates from 9 covering analysts. With the stock currently trading at $2.51, this represents a potential upside of +99.2%. The company has a market capitalization of $149M.
Analyst price targets range from a low of $5.00 to a high of $5.00, representing a 0% spread in expectations. The median target of $5.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CURI trades at a trailing P/E of 6275.0x and forward P/E of 12.7x.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 FUBOfuboTV Inc. | $224M | $7.60 | $63.38 | +733.9% | Hold | — | 15 |
 AMCXAMC Global Media Inc. | $272M | $8.39 | $13.50 | +60.9% | Hold | 7.3x | 41 |
 CXDOCrexendo, Inc. | $164M | $5.07 | $7.25 | +43.0% | Buy | 11.9x | 6 |
 NFLXNetflix, Inc. | $264.0B | $63.41 | $86.21 | +36.0% | Buy | 17.7x | 100 |
 DISThe Walt Disney Company | $202.7B | $116.75 | $125.67 | +7.6% | Buy | 16.9x | 64 |
 FOXAFox Corporation | $29.2B | $66.64 | $70.75 | +6.2% | Buy | 11.2x | 48 |
 ROKURoku, Inc. | $23.8B | $160.52 | $163.08 | +1.6% | Hold | 46.9x | 45 |
 AMZNAmazon.com, Inc. | $2.8T | $259.30 | $328.48 | +26.7% | Buy | 20.2x | 96 |
 AAPLApple Inc. | $5.0T | $342.37 | $344.46 | +0.6% | Buy | 36.2x | 112 |
 GOOGLAlphabet Inc. | $3.4T | $284.78 | $400.32 | +40.6% | Buy | 14.5x | 83 |
Quick answers to the most common questions about buying CURI stock.
The consensus Wall Street price target for CURI is $5, representing 99.2% upside from the current price of $2.51. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CURI has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $5 implies 99.2% upside from current levels.
With a forward P/E of 12.7089x, CURI trades at a relatively low valuation. The consensus target of $5 implies 99.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $5 for CURI, while the most conservative target is $5. The consensus of $5 represents the median expectation. These targets typically reflect 12-month expectations.
CURI is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CURI stock forecast based on 9 Wall Street analysts shows a consensus price target of $5, with estimates ranging from $5 (bear case) to $5 (bull case). The median consensus rating is "Buy".
CURI trades at a forward P/E ratio of 12.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 6275.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CURI, with a "Buy" consensus rating and $5 price target (99.2% upside). 6 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CURI analyst price targets range from $5 to $5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.